Please login to the form below

Not currently logged in
Email:
Password:

Pharming

This page shows the latest Pharming news and features for those working in and with pharma, biotech and healthcare.

EMA starts rapid review of Shire’s HAE antibody

EMA starts rapid review of Shire’s HAE antibody

Other approved treatments for HAE include CSL Behring’s Berinert and Pharming’s Ruconest.

Latest news

  • Opdivo backed for two new uses by CHMP Opdivo backed for two new uses by CHMP

    The CHMP also recommended extensions of indications for Boehringer Ingelheim's Giotrif (afatinib), Abbvie's Humira (adalimumab), Pharming's Ruconest (conestat alfa), Takeda's TachoSil (human thrombin/human fibrinogen) and

  • FDA approves drug for rare swelling diseases FDA approves drug for rare swelling diseases

    Salix and Pharming’s Ruconest is made from the milk of genetically-modified rabbits. ... Ruconest is developed in partnership by Salix Pharmaceutical and Pharming and is intended as a protein replacement in people with hereditary angioedema.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch August 2016 Deal Watch August 2016

    Finally it was interesting to see that Pharming has recovered from Valeant the North American rights to its product Ruconest. ... Pharming did well to get the rights back especially as it resulted in Valeant having to make a $199m write down of its

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...

Infographics